RESEARCH TRIANGLE PARK, N.C., July 14, 2016 /PRNewswire/ -- This week, Marken announced the launch of the Gold Book – the company's premier publication on GDP compliance.
The newly published guide emphasizes the critical nature of GDP compliance for the life science supply chain industry. It offers a complete detailing of GDP guidelines, compliance and impact on the industry and clients. The Gold Standard confirms Marken's dedication to the storage and transportation of drug products and, the company's leading role in developing an extensive certification program as outlined in the book.
Over the past few years, GDP requirements have evolved with the growing needs of the industry. Moreover, violations have brought GDP compliance into the spotlight, bringing increased scrutiny to life science companies from regulatory bodies.
As patient populations become more diverse and dispersed across the world, Marken's Gold Network is a trusted resource for life science companies. Following a significant investment of time and resources beginning in 2014, Marken is proud to confirm that all logistics branches are GDP certified. Compliant with all country regulations, Marken leads the market by complying with the increasingly demanding regulatory requirements through an extensive Quality Management System (QMS) comprised of over 250 SOPs.
Wes Wheeler, Marken's Chief Executive Officer, emphasized Marken's passion to "drive innovation and exceed client expectations and goals." He explained, "That's why we designed a fully integrated GDP compliant network." Wheeler continued, "When it comes to the patient, Marken recognizes the critical nature of product safety and strict regulatory compliance. The investments in our network highlight our focus on ensuring our global footprint is 100% GDP compliant."
To request a copy of the Gold Book, email Marken's team of GDP specialists at [email protected].
About Marken Marken is the only patient-centric supply chain organization 100% dedicated to the pharmaceutical and life sciences industries. Marken maintains the leading position for Direct to Patient services and biological sample shipments, and offers a state of the art GMP-compliant depot network and logistic hubs in 43 locations worldwide. Marken's 630 staff members manage 50,000 drug and biological shipments every month at all temperature ranges in more than 150 countries. Additional services such as biological kit production, ancillary material sourcing, storage and distribution, shipment lane verification and qualifications, as well as GDP, regulatory and compliance consultancy add to Marken's unique position in the pharma and logistics industry.